Annual supplier review meetings tend to produce a recurring tableau: the approved vendor list is long, crowded, and in several categories carries three or four names, while the same year's purchasing spend, once opened line by line, shows a clear majority of the value flowing to a small subset of those names. Nobody in the room is asked to defend the picture, because no decision was ever taken that would require defending. Each purchase order was reasonable in its own moment and on its own terms — lead time was short, the quality record was clean, payment terms had already been negotiated, the production schedule was tight, and there was no sense in taking line-stoppage risk with an untried source. Concentration does not accumulate in that meeting; it accumulates across two hundred separate purchase orders that the meeting never discusses.
The same pattern surfaces a second time whenever a new supplier arrives with a quotation. The comparison is almost always constructed around unit price, whereas the actual cost of moving to a new source sits elsewhere entirely: sampling, first-article approval, a trial run on the line, the rebuilding of a quality record from zero, and, where the part requires it, tooling investment. Every one of those items lands in the procurement function's current-year budget, while the benefit of the transition — remaining operational through a supply interruption, holding a second reference point in a price negotiation — either falls into later years or onto another function's performance line. A choice whose cost is concentrated today in one place and whose payoff is dispersed forward across several is deferred systematically, and the deferral reflects budget architecture rather than any weakness on the part of the decision maker.
What accumulates here is supplier concentration risk — the fragility created when purchasing volume, and more consequentially production continuity, becomes dependent on a small number of counterparties — and the definition matters far less than the conditions under which the position remains functional. Concentration is not an incidental defect. Consolidating volume with one supplier clears discount thresholds, accelerates the learning curve, suppresses specification drift, makes relationship-specific investment economically rational for the supplier — dedicated tooling, reserved line capacity, an assigned quality engineer — and lowers coordination cost across the whole category. A dispersed supply base, safer on paper, means being a smaller customer everywhere, which in a constrained market produces exposure rather than protection. The difficulty lies not in the shortcut itself but in its persistence after the conditions that justified it have moved.
The signals indicating that those conditions have moved typically sit outside what procurement reporting measures. The first is the distinction between single-source and sole-source: a part consolidated with one supplier by preference while other qualified producers exist carries an entirely different risk from a part for which no other producer technically exists, though both appear on the same line of the same table. The second is concealed concentration at the tier below; two nominally independent suppliers drawing from the same raw material producer, the same foundry, or the same electronic component distributor preserve duality at tier one while eliminating it in substance. The third emerges only during contraction, since a supplier moving to an allocation regime distributes capacity by historical volume and continuity of relationship, which leaves the alternate that has sat approved but unordered for years at the back of the queue precisely when it is needed.
The balance-sheet consequence of this structure usually appears not in supply reporting but in working capital. A line dependent on a single source compensates for interruption probability with safety stock; inventory levels rise, turns slow, the cash conversion cycle lengthens, and that lengthening quietly immobilizes cash that would otherwise fund growth. Running parallel to it, bargaining asymmetry expresses itself through payment terms, as the supplier carrying the majority of the volume gradually acquires the capacity to shorten tenor, request advances, or pass through price increases at tighter intervals. Searching for the cost of concentration in unit price therefore yields nothing, because unit price is generally favorable; the charge accumulates in the inventory line, in the structure of payment terms, and in the length of the cash cycle.
The second and sharper consequence arrives when the company changes hands or takes external capital. A party examining the supply base in commercial diligence looks at the contract before the spend table, searching for four things: remaining tenor and termination notice period, the index to which the price revision mechanism is tied, where ownership of tooling, jigs, and technical drawings resides, and whether a change-of-control clause exists. Where the relationship carrying a material share of volume runs on an expired framework agreement or on a course of dealing that was never documented, the finding rarely translates into a direct discount to the multiple; it translates into a constraint on transaction structure — a pre-closing condition requiring contract renewal, an expanded scope of representations and warranties, an escrow ratio adjusted upward, or an earn-out tranche conditioned on supply continuity.
A third consequence sits on the insurance and contractual liability side. Liquidated damages triggered against the company by a supplier-caused interruption are seldom recoverable from that supplier, since the LD cap in the subcontract is bounded by the order value while the cap in the prime contract is measured against the project value. The gap between those two ceilings rests directly with the company on single-sourced items, and standard business interruption cover does not close it; interruption originating at a supplier's facility requires contingent cover, and that cover obliges the insurer to see the supplier by name, which in turn requires the concentration to be disclosed in writing. The cost here accumulates not as a premium differential but as a slice of uninsured obligation.
The mechanism that neutralizes this tendency is not a target for supplier count but a change in where the decision is taken and in what unit it is measured. Four components are workable. The first is the unit of measure: concentration is measured not by share of spend but by the revenue that stops and the delivery commitments that slip if the supplier ceases shipping, and under that measure a component vendor representing two percent of spend can rise to the top of the list. The second is budget architecture, since moving qualification cost out of the procurement function's annual budget and into a central continuity budget dissolves the asymmetry standing in front of the transition decision. The third is flow discipline: the second source is held in production flow at regular small volume rather than on a list, which keeps the quality record live, the line proven, and the allocation-queue position legitimate. The fourth is contract architecture — ownership of tooling and drawings, the exit procedure from the supplier's facility, and last-buy rights on termination, all written at the outset when bargaining leverage is highest.
BEIREK's intervention in this area begins not with retendering the supply base but with building a criticality map, in which each purchased item is annotated not with spend value but with the revenue that halts on interruption, the qualification lead time of a deployable alternate, and the inventory cover required to bridge that interval. That triad ordinarily inverts the ranking of the spend table and moves management attention from the item that consumes the most cash to the item that stops the most work. Layered onto the map, a renewal register consolidates supplier contract expiry and notice dates onto a single calendar; aligned with the timetable for capital decisions, capacity expansion, or a sale process, it makes the leverage available at each renewal known in advance rather than discovered at the table.
The second layer of intervention concerns the timing of the decision record. In practice the move to a single source is recorded at the moment of approval, by which point the alternative has already been eliminated; the cadence installed here pulls it back to the moment of proposal, so that when an item is consolidated the rationale, the period for which it holds, the condition that reopens it, and the person obliged to trigger that reopening are all written down. Such a record does not prohibit single-sourcing; it gives it an expiry date, and every item reaching that date returns to a quarterly review session. The same session interrogates second-tier dependencies — whether two tier-one suppliers rest on a common sub-source, what weight the company carries within the supplier's own customer portfolio, and whether that weight makes it a protected account or an easily released one.
Supplier concentration is the risk that accumulates fastest during a company's strongest operating period, precisely because the speed, quality consistency, and price advantage delivered by a single source are most visible when conditions are good, while the possibility of interruption remains most abstract. The governing question is therefore not how capable a supplier is, but what the counterparty holds when it sits down at the table tomorrow — and the answer to that question was settled when the first order was placed, not when the contract came up for renewal.